At Neunos Ltd, we are developing an implantable, minimal-invasive transcranial neurostimulator device that can automatically detect epileptic seizures and terminate them instantaneously, before fatal accidents occur. Our goal is to combine the most recent theoretical advances of neuroscience with cutting edge technology in electronics to provide novel, non-pharmaceutical treatment options. Although treating epilepsy is our main focus, we are continuously looking for new opportunities and different perspectives to deepen our knowledge in other neurological and neuropsychiatric disorders, and find new therapeutic approaches for them.